With extensive experience in leadership roles for the National Institute on Drug Abuse (NIDA) and the White House Office of National Drug Control Policy (ONDCP), Condon specializes in the fundamental impact of drugs on human behavior and implications for clinical and criminal justice practice.
CHJ is a nonprofit public policy and consulting group that promotes criminal justice and health reform nationally through practical, evidence-based responses to mental health and substance use conditions. The Center grew out of the direct service experience of TASC (Treatment Alternatives for Safe Communities), a statewide organization that since 1976 has provided placement into addiction treatment, case management, and recovery support for hundreds of thousands of Illinoisans, primarily through alternatives to incarceration and reentry programs.
“Dr. Condon’s exceptional experience and knowledge will inform the delivery of our national training and consulting services as well as our internal program evaluation processes,” said TASC President Pamela Rodriguez. “We are honored to announce this partnership, especially at a time when justice and health reform efforts across the country are incorporating new understandings of brain science and research-based practices.”
Among his many accomplishments, Condon guided NIDA in building its research, training infrastructure, bringing science-based findings to community treatment programs, and establishing a national communications network for information sharing and research collaboration. He was instrumental in establishing the national NIDA Clinical Trials Network to conduct research in real-life treatment settings with diverse populations. In addition, he established the NIDA/Substance Abuse and Mental Health Services (SAMHSA) Blending Initiative to reduce the substantial lag time between research discoveries and the implementation of these finding into clinical practice.
At ONDCP, his expertise informed the development of the National Drug Control Strategy and the nation’s demand reduction activities, including the integration of primary and behavioral health delivery, the treatment of substance use disorders among criminal justice populations, evidence-based approaches to prescription drug abuse, and the implications of health care reform for policy, practice, and workforce development. Condon was one of the authors of the national Prescription Drug Abuse Prevention Plan released in 2011.
“I have been working with TASC and CHJ for a number of years as deputy director of NIDA and am honored to provide whatever expertise I can to TASC as it creates new opportunities to improve social justice for those in the criminal justice system and to ensure that those suffering from addiction and other behavioral health disorders get the treatment that they need,” Condon said.
“At TASC and our Center for Health and Justice, it is with both pride and humility that we have the opportunity to work with innovative thinkers and influential change agents across the country,” Rodriguez added. “Together we are committed to meaningful strategies, practices, and policies to improve health and justice. It is in this environment that we happily welcome Dr. Condon to our expansive team of dedicated partners and colleagues.”